Interferon beta preparations for the treatment of multiple sclerosis patients differ in neutralizing antibody seroprevalence and immunogenicity - Sominanda, A; Rot, U; Suoniemi, M; Deisenhammer, F; Hillert, J; Fogdell-Hahn, A (Mult Scler, 2007)